Patents Assigned to University
-
Publication number: 20030157637Abstract: This invention relates to the PrtR-PrtK cell surface protein of Porphyromonas gingivalis and in particular a multimeric cell associated protein complex comprising the PrtR and PrtK proteins. Accordingly the invention provides a substantially purified antigenic complex for use in raising an antibody response directed against Porphyromonas gingivalis. The complex comprises at least one multimeric protein complex of arginine-specific and lysine-specific thiol endopeptidases each containing at least one adhesin domain, the complex having a molecular weight of greater than about 200 kDa. The invention also relates to pharmaceutical compositions and associated agents based on said complex for the detection, prevention and treatment of Periodontal disease associated with P. gingivalis.Type: ApplicationFiled: August 28, 2002Publication date: August 21, 2003Applicant: The University of MelbourneInventors: Eric Charles Reynolds, Peter Singh Bhogal, Nada Slakeski
-
Publication number: 20030157692Abstract: The present invention is discloses an improved method of producing infectious papillomavirus in vitro, with a method comprising (a) introducing papillomavirus or papillomavirus DNA or portions thereof necessary for replication, into an epithelial cell; and (b) providing conditions that produce papillomavirus, wherein the conditions comprise not contacting the epithelial cell a fibroblast and does not comprise an organotypic raft culture or a dermal equivalent. The present invention also discloses a papillomavirus infected non-keratinocyte epithelial cell produced by the methods of the present invention. Further, uses of the disclosed method includes detection methods, methods for screening anti-papillomavirus drugs, methods of making recombinant papillomavirus for vaccines and studying the life cycle. Additionally, a method of reducing and assessing the risk of spontaneous abortion is disclosed.Type: ApplicationFiled: December 16, 2002Publication date: August 21, 2003Applicant: University of ArkansasInventors: Paul L. Hermonat, Yong Liu
-
Publication number: 20030156523Abstract: The present invention includes an optical system to control and optimize molecular reorientation for information storage. A preferred embodiment of the invention utilizes light sources emitting at wavelengths centered on or around the absorption bands of the storage medium. The light can be selectively polarized to control orientation of molecular components of organic material to provide non-volatile storage of large amounts of information. This provides an alternative to magnetic, electric, magneto-optical, or electro-optical methods which are complex and expensive. The all-optical holographic method in accordance with the present invention provides a storage system with extremely high memory capacity. In accordance with another aspect of the present invention, a system for optically storing and retrieving data includes optically recording (writing) and retrieving (reading) with the same wavelength beam, for example, without additional conditions such as an electric or magnetic field.Type: ApplicationFiled: February 15, 2002Publication date: August 21, 2003Applicant: University of MassachusettsInventors: Pengfei Wu, D.V.G.L.N. Rao
-
Publication number: 20030157539Abstract: Isolated nucleic acid encoding the amino acid sequence of murine IRAK-M; expression vectors comprising nucleic acid encoding IRAK-M and host cells comprising them are disclosed. IRAK-M is induced upon toll-like receptor (TLR) stimulation and negatively regulates TLR signaling. Methods for identifying antagonists and agonists of IRAK-M are described.Type: ApplicationFiled: January 9, 2003Publication date: August 21, 2003Applicant: Yale UniversityInventors: Richard A. Flavell, Koichi Kobayashi, Ruslan M. Medzhitov
-
Publication number: 20030157078Abstract: The present invention provides a molecular marker for the identification of pluripotent pre-mesenchymal, pre-hematopoietic stem cells. The invention further provides primitive progenitor cells identified by the molecular marker. Such cells have the potential to differentiate into both mesenchymal and hematopoietic phenotypes, as determined by a proliferative response to inductive growth factors and cytokines, and by their morphologic and cytochemical features.Type: ApplicationFiled: March 31, 2003Publication date: August 21, 2003Applicant: University of Southern California, a California corporationInventors: Frederick L. Hall, Erlinda M. Gordon
-
Patent number: 6608386Abstract: A new class of electronic systems, wherein microelectronic semiconductor integrated circuit devices are integrated on a common substrate with molecular electronic devices.Type: GrantFiled: November 19, 2001Date of Patent: August 19, 2003Assignee: Yale UniversityInventors: Mark A. Reed, James M. Tour
-
Patent number: 6607709Abstract: A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells.Type: GrantFiled: October 11, 2000Date of Patent: August 19, 2003Assignee: The Curators of the University of MissouriInventors: Silvia S. Jurisson, Thomas P. Quinn, Michael F. Giblin
-
Patent number: 6607782Abstract: Methods for coating a substrate and methods of shaping a workpiece comprise formation and use, respectively, of a surface or substrate comprising a first phase selected from nitrides, carbides. carbonitrides, borides, sulphides, chalcogenides, oxides, and silicides, and a second phase selected from nitrides, carbides, carbonitrides, borides, sulphides, chalcogenides, oxides, and silicides, wherein said second phase comprises a multiplicity of discrete portions positioned into the first phase, with these multiplicity of portions comprising a continuous second phase, and made thereof, coating and articles, especially machining, cutting and shaping tools, wearparts, and methods of making and using the composition, coating and articles.Type: GrantFiled: June 29, 2000Date of Patent: August 19, 2003Assignees: Board of Trustees of the University of Arkansas, Valenite, Inc.Inventors: Ajay P. Malshe, Sharad N. Yedave, William D. Brown, William C. Russell, Deepak G. Bhat
-
Patent number: 6608474Abstract: A frequency change measuring device includes frequency divider for frequency dividing a measuring signal to produce frequency-divided signals, first counter for counting the frequency-divided signals to calculate frequency-division numbers, frequency division numbers transmitter for transmitting the frequency division numbers in synchronism with the frequency-divided signals, frequency division numbers receiver for receiving the frequency division numbers transmitted from the frequency division numbers transmitter, second counter for counting outputs of a reference clock generator synchronized with a timekeeping device that keeps the standard time, latch unit for latching a count of frequency outputs of the reference clock generator synchronous for generating reference clocks on the basis of signals synchronous with the frequency division numbers, and operations unit for determining a frequency change on the basis of the count and the frequency division numbers.Type: GrantFiled: March 29, 2001Date of Patent: August 19, 2003Assignee: President of Nagoya UniversityInventor: Tsuneo Yamauchi
-
Patent number: 6607698Abstract: A system and method for increasing gas concentration in blood which has use as a generalized extracorporeal system and method to treat hypoxemic blood from a patient by mixing the blood with an oxygen supersaturated solution to generate hyperoxemic blood to be infused back to the patient. The extracorporeal system comprises an extracorporeal tubing through which blood from the patient is circulated, a blood pump for withdrawing blood from and delivering blood to the patient, at least one channel for delivering oxygen-supersaturated fluid and a mixing region for introducing supersaturated fluid without bubble formation. By infusing the oxygen-supersaturated fluid into the hypoxemic or normoxemic blood from the patient, hyperoxemic blood is thereby produced. The hyperoxemic blood is then returned to a central vein, right heart or artery of the patient with the blood pump at approximately the same volume delivery rate as blood volume withdrawal rate.Type: GrantFiled: August 15, 1997Date of Patent: August 19, 2003Assignees: TherOx, Inc., Wayne State UniversityInventors: J. Richard Spears, Seth A. Foerster, James M. Gessert, Paul J. Zalesky
-
Patent number: 6606887Abstract: An anti-theft equipment locking cover, including a first cover part adapted to overlie a first part of an item of equipment; the first cover part having a flange adapted to underlie a first edge of the item of equipment; a second cover part to overlie a second part of the item of equipment; the second cover part having a flange adapted to underlie a second edge of the item of equipment; the first and second cover parts being disposed in confronting relation to one another so that the item of equipment is fully covered by the confronting first and second cover parts; a tab secured to the first cover part; a slot formed in the second cover part that slideably receives the tab; a distal free end of the tab extending through the slot; an aperture formed in the distal free end of the tab; and a locking device adapted to extend through the aperture to prevent retraction of the tab from the slot.Type: GrantFiled: December 5, 2001Date of Patent: August 19, 2003Assignee: University of South FloridaInventors: David Zimmer, John LeBlanc, Decha Narkmongkon, Raymond H. Williams
-
Patent number: 6607897Abstract: Recombinant proCVF exhibits substantially the same activity as CVF and is useful for lowering complement activity.Type: GrantFiled: August 10, 2001Date of Patent: August 19, 2003Assignee: Georgetown UniversityInventors: Carl-Wilhelm Vogel, Reinhard Bredehorst, David Fritzinger, Michael Kock
-
Patent number: 6608102Abstract: The present invention is directed to isolation and identification of plant proanthocyanidin extracts and particular proanthocyanidin compounds for prevention and treatment of urinary tract infections caused by P-type Escherichia coli. These extracts can be obtained from any proanthocyanidin-containing plants, including plants of the families Ericaceae, Rosaceae, Pinaceae, Vitaceae and the like. Preferably the extracts are from cranberry plants (especially, Vaccinium macrocarpon) and other plants, particularly fruit and berry plants from the Vaccinium spp. The extracts and compounds are also provided as pharmaceutical compositions, food additives and food compositions, especially beverages, ground meat preparations and cranberry-containing food products. The invention also relates to methods of reducing pathogenicity of P-type E. coli in the digestive tracts of cattle and reducing P-type E. coli contamination in ground meat as well as methods of detecting P-type bacteria.Type: GrantFiled: September 2, 1998Date of Patent: August 19, 2003Assignee: Rutgers, the State University of New JerseyInventors: Amy B. Howell, Nicholi Vorsa
-
Patent number: 6607487Abstract: A system for assisting in precise location of the acetabular implant during total hip replacement. The system uses ultrasound imaging for guiding the placement and orientation of the implant.Type: GrantFiled: January 23, 2001Date of Patent: August 19, 2003Assignee: The Regents of the University of CaliforniaInventors: John Chang, Waleed Haddad, Jan-Ulco Kluiwstra, Dennis Matthews, Kenneth Trauner
-
Patent number: 6607595Abstract: Disclosed herein are (1) a light-emitting semiconductor device that uses a gallium nitride compound semiconductor (AlXGa1-xN) in which the n-layer of n-type gallium nitride compound semiconductor (AlxGa1-XN) is of double-layer structure including an n-layer of low carrier concentration and an n+-layer of high carrier concentration, the former being adjacent to the i-layer of insulating gallium nitride compound semiconductor (AlxGa1-xN); (2) a light-emitting semiconductor device of similar structure as above in which the i-layer is of double-layer structure including an iL-layer of low impurity concentration containing p-type impurities in comparatively low concentration and an iH-layer of high impurity concentration containing p-type impurities in comparatively high concentration, the former being adjacent to the n-layer; (3) a light-emitting semiconductor device having both of the above-mentioned features and (4) a method of producing a layer of an n-type gallium nitride compound semiconductor (AlxGa1-xType: GrantFiled: October 2, 2000Date of Patent: August 19, 2003Assignees: Toyoda Gosei Co., Ltd., Kabushiki Kaisha Toyota Chuo Kenkyu sho, Nagoya University, Japan Science and Technology CorporationInventors: Katsuhide Manabe, Akira Mabuchi, Hisaki Kato, Michinari Sassa, Norikatsu Koide, Shiro Yamazaki, Masafumi Hasimoto, Isamu Akasaki
-
Patent number: 6607777Abstract: A textured whey protein product for use as a meat extender or meat analog is prepared by thermoplastic extrusion of a composition containing whey protein concentrate and optionally an edible polysaccharide, such as cornstarch. Puffing of the extruded product results in a snack food product. Methods of making the meat extender product and the snack food product are also included.Type: GrantFiled: June 16, 2000Date of Patent: August 19, 2003Assignee: Utah State UniversityInventors: Marie K. Walsh, Charles E Carpenter
-
Patent number: 6607741Abstract: Compounds of the general formula P1-L-P2; wherein “P1” is a pyrazinoylguanidine sodium channel blocker, “L” is a linking group, and “P2” is either (i) a pyrazinoylguanidine sodium channel blocker or (ii) a P2Y2 receptor agonist, are disclosed. Pharmaceutical formulations containing the same and methods of use thereof to hydrate mucosal surfaces such as airway mucosal surfaces are also disclosed.Type: GrantFiled: April 12, 2002Date of Patent: August 19, 2003Assignee: The University of North Carolina at Chapel HillInventor: Richard C. Boucher, Jr.
-
Patent number: 6608187Abstract: The invention relates to the identification of C1 bacteriophage genes that express protein involved in the lysis of bacterial cells during the phage life cycle, lysin and holin. The invention further relates to methods for lysing certain bacteria using lysin, which are useful for example in the treatment of an oral cavity bacterial infection.Type: GrantFiled: May 23, 2001Date of Patent: August 19, 2003Assignee: The Rockefeller UniversityInventors: Daniel C. Nelson, Vincent A. Fischetti
-
Patent number: 6608774Abstract: Selected domains, normally 2×103×2×103 such domains arrayed in a plane, within a three-dimensional (3-D) volume of radiation-sensitive medium, typically 1 cm3 of spirobenzopyran containing 2×103 such planes, are temporally and spatially simultaneously illuminated by two radiation pulses, normally laser light pulses in various combinations of wavelengths 532 nm and 1024 nm, in order, dependent upon the particular combination of illuminating light, to either write binary data to, or read binary data from, the selected domains by process of two-photon (2-P) interaction/absorption. One laser light pulse is preferably directed to illuminate all domains during its propagation along one directional axis of the volume. The other laser light pulse is first spatially encoded with binary information by 2-D spatial light modulator, and is then (i) directed and (ii) time sequenced to intersection with the other light pulse in a locus of intersection domains.Type: GrantFiled: May 30, 1995Date of Patent: August 19, 2003Assignee: The Regents of the University of CaliforniaInventor: Peter M. Rentzepis
-
Patent number: 6608241Abstract: The invention involves recombinant, double-stranded DNA that contains a promoter which functions in plant cells to cause the production of RNA sequences of a plant virus, a DNA sequence that causes the production of an RNA sequence encoding the coat protein of said plant virus, and a 3′ non-translated region which functions in plant cells to cause the addition of polyadenylated nucleotides to the 3′ end of said RNA sequence; which double-stranded DNA can be used in a method for genetically transforming plants to produce genetically transformed plant cells and plants that are resistant to virus infection.Type: GrantFiled: October 9, 1986Date of Patent: August 19, 2003Assignees: Monsanto Technology LLC, Washington UniversityInventors: Roger N. Beachy, Robert T. Fraley, Stephen G. Rogers